Animal research is saving lives, but funding is needed to improve welfare: Submission to the New South Wales parliamentary inquiry

Author:

Khoo Shaun Yon-Seng123ORCID,Kendig Michael D.2ORCID,Bradfield Laura A.2ORCID

Affiliation:

1. Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada

2. School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW, Australia

3. Present Address: Conduct and Integrity Office, Division of Planning and Assurance, UNSW Sydney, NSW, Australia

Abstract

Many kinds of animal research are occurring in New South Wales (NSW), with biomedical research among the most prominent. As behavioural neuroscientists, we study the neural mechanisms of motivation and cognition in rodents, which is important for developing new treatments for a range of psychological disorders, such as substance use disorder, as well as neurodegenerative diseases such as Alzheimer’s. The welfare and wellbeing of the animals we study is of critical importance, not only to ensure the quality of our data but to our sense of morality as compassionate human beings. Biomedical animal research is highly regulated and the pharmacological and biological tools we use pose negligible risks to the public. Meanwhile, our research brings enormous benefits to NSW by building expertise and supporting biotechnology companies. Although research on complex behaviours cannot be replaced by non-animal procedures, we believe that there is much scope for refinement and improvement in animal welfare in NSW. For example, investing in a local breeding facility to produce animals used in NSW research projects would significantly reduce the stress associated with importing animals from interstate or overseas. Additionally, standard animal housing could be improved through targeted and ongoing investment to refit animal facilities and support additional caretaker and veterinary staff to provide higher degrees of welfare.

Funder

Fonds de Recherche du Québec - Santé

National Health and Medical Research Council

Australian Research Council

Publisher

Episteme Health Inc

Subject

General Medicine

Reference16 articles.

1. Portfolio Committee No 2 - Health. Media release: New parliamentary inquiry into the use of primates and other animals in medical research in NSW; 2022 [cited 2022-02-01]. Available from: https://www.parliament.nsw.gov.au/lcdocs/other/16595/Media%20release%20-%20PC2%20-%20New%20Inquiry%20into%20animal%20medical%20research.pdf. Archived: https://web.archive.org/web/20220201055252/https://www.parliament.nsw.gov.au/lcdocs/other/16595/Media%20release%20-%20PC2%20-%20New%20Inquiry%20into%20animal%20medical%20research.pdf.

2. Portfolio Committee No 2 - Health. Inquiry into the use of primates and other animals in medical research in New South Wales: Terms of reference; 2022 [cited 2022-02-17].Available from: https://www.parliament.nsw.gov.au/lcdocs/inquiries/2857/Terms%20of%20Reference%20-%20PC%202%20-%20Medical%20research%20on%20animals.pdf. Archived: https://web.archive.org/web/20220217031542/https://www.parliament.nsw.gov.au/lcdocs/inquiries/2857/Terms%20of%20Reference%20-%20PC%202%20-%20Medical%20research%20on%20animals.pdf.

3. Chan JFW, Yuan S, Zhang AJ, Poon VKM, Chan CCS, Lee ACY, et al. Surgical mask partition reduces the risk of noncontact transmission in a golden syrian hamster model for coronavirus disease 2019 (COVID-19). Clinical Infectious Diseases. 2020;71(16):2139–2149. doi: 10.1093/cid/ciaa644.

4. Health Protection NSW. COVID-19 vaccination in NSW (18 March 2022); 2022 [cited 2022-03-20]. Available from: https://www.health.nsw.gov.au/Infectious/covid-19/vaccine/Pages/default.aspx. Archived: https://web.archive.org/web/20220320115720/https://www.health.nsw.gov.au/Infectious/covid-19/vaccine/Pages/default.aspx.

5. Pfizer, BioNTech. Pfizer and BioNTech announce data from preclinical studies of mRNA-based vaccine candidate against COVID-19; 2020 [cited 2022-03-07]. Available from: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-data-preclinical-studies-mrna. Archived: https://web.archive.org/web/20220307024140/https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-data-preclinical-studies-mrna.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3